Michael R Mcdonnell - Net Worth and Insider Trading
Michael R Mcdonnell Net Worth
The estimated net worth of Michael R Mcdonnell is at least $3 Million dollars as of 2023-03-31. Michael R Mcdonnell is the EVP and CFO of IQVIA Holdings Inc and owns about 14,366 shares of IQVIA Holdings Inc (IQV) stock worth over $3 Million. Michael R Mcdonnell is also the Former EVP, CFO of DISH Network Corp and owns about 720 shares of DISH Network Corp (DISH) stock worth over $6,487. Details can be seen in Michael R Mcdonnell's Latest Holdings Summary section.
Transaction Summary of Michael R Mcdonnell
Michael R Mcdonnell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael R Mcdonnell owns 7 companies in total, including Biogen Inc (BIIB) , IQVIA Holdings Inc (IQV) , and Frontier Communications Corp (FTRPR.PFD) among others .
Click here to see the complete history of Michael R Mcdonnell’s form 4 insider trades.
Insider Ownership Summary of Michael R Mcdonnell
|Ticker||Comapny||Transaction Date||Type of Owner|
|BIIB||Biogen Inc||2020-08-15||EVP & Chief Financial Officer|
|IQV||IQVIA Holdings Inc||2015-12-16||Chief Financial Officer|
|FTRPR.PFD||Frontier Communications Corp||2019-04-01||director|
|IMS||IMS Health Holdings Inc||2017-07-05||EVP and CFO|
|DISH||DISH Network Corp||2004-06-30||EVP & Chief Financial Officer|
|FYBR||Frontier Communications Parent Inc||2018-12-12||director|
|MMSI||Merit Medical Systems Inc||2022-05-19||director|
Michael R Mcdonnell Latest Holdings Summary
Michael R Mcdonnell currently owns a total of 2 stocks. Among these stocks, Michael R Mcdonnell owns 14,366 shares of IQVIA Holdings Inc (IQV) as of January 2, 2020, with a value of $3 Million and a weighting of 99.77%. Michael R Mcdonnell also owns 720 shares of DISH Network Corp (DISH) as of September 7, 2004, with a value of $6,487 and a weighting of 0.23%.
Latest Holdings of Michael R Mcdonnell
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|IQV||IQVIA Holdings Inc||2020-01-02||14,366||194.95||2,800,652|
|DISH||DISH Network Corp||2004-09-07||720||9.01||6,487|
Holding Weightings of Michael R Mcdonnell
Michael R Mcdonnell Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael R Mcdonnell has made a total of 2 transactions in IQVIA Holdings Inc (IQV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in IQVIA Holdings Inc is the sale of 12,000 shares on January 2, 2020, which brought Michael R Mcdonnell around $2 Million.
According to the SEC Form 4 filings, Michael R Mcdonnell has made a total of 0 transactions in DISH Network Corp (DISH) over the past 5 years. The most-recent trade in DISH Network Corp is the sale of 12,000 shares on September 7, 2004, which brought Michael R Mcdonnell around $371,880.
Insider Trading History of Michael R Mcdonnell
Michael R Mcdonnell Trading Performance
Michael R Mcdonnell Ownership Network
Ownership Network List of Michael R Mcdonnell
Ownership Network Relation of Michael R Mcdonnell
Michael R Mcdonnell Owned Company Details
What does Biogen Inc do?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Who are the key executives at Biogen Inc?
Michael R Mcdonnell is the EVP & Chief Financial Officer of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Michael R Mcdonnell made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .
In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Michael R Mcdonnell Mailing Address
Above is the net worth, insider trading, and ownership report for Michael R Mcdonnell. You might contact Michael R Mcdonnell via mailing address: C/o Iqvia Holdings Inc., 83 Wooster Heights Road, Danbury Ct 06810.